Dr. Erin Tree
@drtinytree.bsky.social
Pediatric rheumatologist, mother, foodie, reader, traveler, sports fan, chocoholic | #MedSky #RheumSky #PedsRheumSky
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
October 27, 2025 at 3:53 PM
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: Window of opportunity
⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo)
⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx
#ACR25 #ACRambassador
⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo)
⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx
#ACR25 #ACRambassador
October 27, 2025 at 3:53 PM
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: Window of opportunity
⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo)
⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx
#ACR25 #ACRambassador
⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo)
⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
October 27, 2025 at 3:31 PM
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis?
#ACR25 #ACRambassador
1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis?
#ACR25 #ACRambassador
October 27, 2025 at 3:31 PM
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis?
#ACR25 #ACRambassador
1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis?
#ACR25 #ACRambassador
Looking forward to starting my day off in the Networking Lounges for the AMIGO event at 8:20 AM. Hope to see many fellow #pedsrheum there!
#ACR25 #ACRambassador #pedsrheumsky
#ACR25 #ACRambassador #pedsrheumsky
October 27, 2025 at 1:21 PM
Looking forward to starting my day off in the Networking Lounges for the AMIGO event at 8:20 AM. Hope to see many fellow #pedsrheum there!
#ACR25 #ACRambassador #pedsrheumsky
#ACR25 #ACRambassador #pedsrheumsky
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Deprescribing
-a large number of patients JIA flare off therapy
-lower uveitis recurrence with slower ADA tapering schedule
#ACRambassador
-a large number of patients JIA flare off therapy
-lower uveitis recurrence with slower ADA tapering schedule
#ACRambassador
October 26, 2025 at 8:02 PM
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Deprescribing
-a large number of patients JIA flare off therapy
-lower uveitis recurrence with slower ADA tapering schedule
#ACRambassador
-a large number of patients JIA flare off therapy
-lower uveitis recurrence with slower ADA tapering schedule
#ACRambassador
Dr. Nigrovic presents #pedsrheum Basic & Translational Year in Review at #ACR25:
1. JIA
2. MAS
3. JDM
4. SLE
5. Monogenic diseases
1. JIA
2. MAS
3. JDM
4. SLE
5. Monogenic diseases
October 26, 2025 at 6:57 PM
Dr. Nigrovic presents #pedsrheum Basic & Translational Year in Review at #ACR25:
1. JIA
2. MAS
3. JDM
4. SLE
5. Monogenic diseases
1. JIA
2. MAS
3. JDM
4. SLE
5. Monogenic diseases
Calling all #pedsrheum researchers at #ACR25!
Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training.
#pedsrheumsky
Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training.
#pedsrheumsky
October 26, 2025 at 6:51 PM
Calling all #pedsrheum researchers at #ACR25!
Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training.
#pedsrheumsky
Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training.
#pedsrheumsky
Drs. Linda Hiraki and Bonnie Bermas discuss applying 2025 SLE Guidelines to #cSLE
⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood
⭐️ Mental health screening is 🔑
⭐️Impact on growth
⭐️Monitor school attendance/performance
⭐️Transition
#ACR25 #ACRambassador #pedsrheumsky
⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood
⭐️ Mental health screening is 🔑
⭐️Impact on growth
⭐️Monitor school attendance/performance
⭐️Transition
#ACR25 #ACRambassador #pedsrheumsky
October 26, 2025 at 3:14 PM
Drs. Linda Hiraki and Bonnie Bermas discuss applying 2025 SLE Guidelines to #cSLE
⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood
⭐️ Mental health screening is 🔑
⭐️Impact on growth
⭐️Monitor school attendance/performance
⭐️Transition
#ACR25 #ACRambassador #pedsrheumsky
⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood
⭐️ Mental health screening is 🔑
⭐️Impact on growth
⭐️Monitor school attendance/performance
⭐️Transition
#ACR25 #ACRambassador #pedsrheumsky
The 2025 ACR extrarenal SLE guideline includes 36 graded recommendations
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
October 26, 2025 at 2:49 PM
The 2025 ACR extrarenal SLE guideline includes 36 graded recommendations
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
October 26, 2025 at 1:58 PM
#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
#ACR25 Clinical Year in Review by Dr. Bryant England (1/2): #Sjogren
⭐️ “The name has caught up to the science in Sjogren’s.”
⭐️ Potential role for salivary autoantibodies
#ACRambassador
⭐️ “The name has caught up to the science in Sjogren’s.”
⭐️ Potential role for salivary autoantibodies
#ACRambassador
October 26, 2025 at 1:58 PM
#ACR25 Clinical Year in Review by Dr. Bryant England (1/2): #Sjogren
⭐️ “The name has caught up to the science in Sjogren’s.”
⭐️ Potential role for salivary autoantibodies
#ACRambassador
⭐️ “The name has caught up to the science in Sjogren’s.”
⭐️ Potential role for salivary autoantibodies
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (3/3):
Emerging conference themes
⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky
⭐️AI: resource provided for those interested in learning more
#ACRambassador
Emerging conference themes
⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky
⭐️AI: resource provided for those interested in learning more
#ACRambassador
October 26, 2025 at 1:35 PM
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (3/3):
Emerging conference themes
⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky
⭐️AI: resource provided for those interested in learning more
#ACRambassador
Emerging conference themes
⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky
⭐️AI: resource provided for those interested in learning more
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (2/3):
Take home messages about the progression of RA from preclinical to clinical state
#ACRambassador
Take home messages about the progression of RA from preclinical to clinical state
#ACRambassador
October 26, 2025 at 1:35 PM
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (2/3):
Take home messages about the progression of RA from preclinical to clinical state
#ACRambassador
Take home messages about the progression of RA from preclinical to clinical state
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (1/3):
🔑 papers from the past 12 months
#ACRambassador
🔑 papers from the past 12 months
#ACRambassador
October 26, 2025 at 1:35 PM
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (1/3):
🔑 papers from the past 12 months
#ACRambassador
🔑 papers from the past 12 months
#ACRambassador
What a great start to #ACR25!
The Opening Session featured a keynote by Dr. Tait Shanafelt, who spoke on the very relevant topic of clinician well-being.
It was great seeing familiar faces at the grand opening networking event and at the @hspecialsurgery.bsky.social alumni event!
#ACRambassador
The Opening Session featured a keynote by Dr. Tait Shanafelt, who spoke on the very relevant topic of clinician well-being.
It was great seeing familiar faces at the grand opening networking event and at the @hspecialsurgery.bsky.social alumni event!
#ACRambassador
October 26, 2025 at 2:25 AM
What a great start to #ACR25!
The Opening Session featured a keynote by Dr. Tait Shanafelt, who spoke on the very relevant topic of clinician well-being.
It was great seeing familiar faces at the grand opening networking event and at the @hspecialsurgery.bsky.social alumni event!
#ACRambassador
The Opening Session featured a keynote by Dr. Tait Shanafelt, who spoke on the very relevant topic of clinician well-being.
It was great seeing familiar faces at the grand opening networking event and at the @hspecialsurgery.bsky.social alumni event!
#ACRambassador
Genetic testing in #pedsrheum by Dr. Troy Torgerson at #ACR24
⭐️ Features 🚩
-Too young
-Too much
-Too weird
-Combinations of above
-Fam hx of immune dysregulation
⭐️ Reduced penetrance & variable expressivity are common features of PIRDS
#ACRAmbassador
⭐️ Features 🚩
-Too young
-Too much
-Too weird
-Combinations of above
-Fam hx of immune dysregulation
⭐️ Reduced penetrance & variable expressivity are common features of PIRDS
#ACRAmbassador
November 18, 2024 at 2:35 PM
Genetic testing in #pedsrheum by Dr. Troy Torgerson at #ACR24
⭐️ Features 🚩
-Too young
-Too much
-Too weird
-Combinations of above
-Fam hx of immune dysregulation
⭐️ Reduced penetrance & variable expressivity are common features of PIRDS
#ACRAmbassador
⭐️ Features 🚩
-Too young
-Too much
-Too weird
-Combinations of above
-Fam hx of immune dysregulation
⭐️ Reduced penetrance & variable expressivity are common features of PIRDS
#ACRAmbassador
November 18, 2024 at 2:19 PM